Biotherapeutics Cell Line Development Market By Process and Application - Global Industry Analysis & Forecast to 2025

Published On : October 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC101524

Biotherapeutics Cell Line Development Market By Process (Single Cell Cloning, Transfection & Selection), Application (Outsource, Do-It-Yourself (DIY), In-house, Hybrid) - Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

The Biotherapeutics Cell Line Development Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Cell-line development has been a progressing need in the life sciences sector. With cell-and tissue-based tests quickly supplanting creature examines, scientists are progressively dependent on cells that can exhibit more prominent organic significance. Correspondingly, therapeutic biotechnology is continually trying to enhance generation cells' execution concerning profitability and product quality.

Drivers and Restraints

With the expanding number of recombinant protein therapeutics picking up endorsement by the U.S. Food and Drug Administration (FDA) yearly, there is an expansion in the interest of cell lines for generation of these biotherapeutics. From 2006 to 2011 around 15 novel recombinant protein therapeutics and in 2014, 11 novel recombinant protein therapeutics have been affirmed by US FDA. Around forty-seven monoclonal antibody products have been affirmed in the U.S., Europe and other worldwide markets, of which more than 60% were delivered in mammalian cell culture. Besides, the ascent in the aged populace combined with predominance of ailments is one of the main considerations driving the interest for cell line advancement for biotherapeutics. The expanding interest for monoclonal antibodies over the globe supports the market development.

Regional Insights

North America has represented the leading position in the worldwide market for biotherapeutics cell line development. Europe, which developed second in this market in 2014, is anticipated to report steady development in the upcoming years.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Lonza Group
  • Catalent
  • CMC Biologics
  • Thermo Fisher Scientific
  • ProBioGen AG
  • Boehringer Ingelheim Pharma GmbH & Co KG
  • Sony Biotechnology Inc
  • Beckman Coulter
  • Partec GmbH
  • Becton Dickinson

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Biotherapeutics Cell Line Development Market, By Process, Estimates and Forecast, 2014-2025 ($Million)

·         Single Cell Cloning

·         Transfection & Selection

·         Biotherapeutics Cell Line Development Market, By Application, Estimates and Forecast, 2014-2025 ($Million)

·         Outsource

·         Do-It-Yourself (DIY)

·         In-house

·         Hybrid

·         Biotherapeutics Cell Line Development Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

·         North America

§  North America Biotherapeutics Cell Line Development Market, By Country

o    U.S. Biotherapeutics Cell Line Development Market

o    Canada Biotherapeutics Cell Line Development Market

o    Mexico Biotherapeutics Cell Line Development Market

·         Europe

§  Europe Biotherapeutics Cell Line Development Market, By Country

o    Germany Biotherapeutics Cell Line Development Market

o    UK Biotherapeutics Cell Line Development Market

o    France Biotherapeutics Cell Line Development Market

o    Russia Biotherapeutics Cell Line Development Market

o    Italy Biotherapeutics Cell Line Development Market

o    Rest of Europe Biotherapeutics Cell Line Development Market

·         Asia-Pacific

§  Asia-Pacific Biotherapeutics Cell Line Development Market, By Country

o    China Biotherapeutics Cell Line Development Market

o    Japan Biotherapeutics Cell Line Development Market

o    South Korea Biotherapeutics Cell Line Development Market

o    India Biotherapeutics Cell Line Development Market

o    Southeast Asia Biotherapeutics Cell Line Development Market

o    Rest of Asia-Pacific Biotherapeutics Cell Line Development Market

·         South America

§  South America Biotherapeutics Cell Line Development Market

o    Brazil Biotherapeutics Cell Line Development Market

o    Argentina Biotherapeutics Cell Line Development Market

o    Columbia Biotherapeutics Cell Line Development Market

o    Rest of South America Biotherapeutics Cell Line Development Market

·         Middle East and Africa

§  Middle East and Africa Biotherapeutics Cell Line Development Market

o    Saudi Arabia Biotherapeutics Cell Line Development Market

o    UAE Biotherapeutics Cell Line Development Market

o    Egypt Biotherapeutics Cell Line Development Market

o    Nigeria Biotherapeutics Cell Line Development Market

o    South Africa Biotherapeutics Cell Line Development Market

o    Rest of MEA Biotherapeutics Cell Line Development Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Biotherapeutics Cell Line Market, By Process

5.1.     Introduction

5.2.     Global Biotherapeutics Cell Line Revenue and Market Share by Process (2014-2018)

5.2.1.  Global Biotherapeutics Cell Line Revenue and Revenue Share by Process (2014-2018)

5.3.     Single Cell Cloning

5.3.1.  Global Single Cell Cloning Revenue and Growth Rate (2014-2018)

5.4.     Transfection & Selection

5.4.1.  Global Transfection & Selection Revenue and Growth Rate (2014-2018)

6.       Biotherapeutics Cell Line Market, By Application

6.1.     Introduction

6.2.     Global Biotherapeutics Cell Line Revenue and Market Share by Application (2014-2018)

6.2.1.  Global Biotherapeutics Cell Line Revenue and Revenue Share by Application (2014-2018)

6.3.     Outsource

6.3.1.  Global Outsource Revenue and Growth Rate (2014-2018)

6.4.     Do-It-Yourself (DIY)

6.4.1.  Global Do-It-Yourself (DIY) Revenue and Growth Rate (2014-2018)

6.5.     In-house

6.5.1.  Global In-house Revenue and Growth Rate (2014-2018)

6.6.     Hybrid

6.6.1.  Global Hybrid Revenue and Growth Rate (2014-2018)

7.       Biotherapeutics Cell Line Market, By Region

7.1.     Introduction

7.2.     Global Biotherapeutics Cell Line Revenue and Market Share by Regions

7.2.1.  Global Biotherapeutics Cell Line Revenue by Regions (2014-2018)

7.3.     North America Biotherapeutics Cell Line by Countries

7.3.1.  North America Biotherapeutics Cell Line Revenue and Growth Rate (2014-2018)

7.3.2.  North America Biotherapeutics Cell Line Revenue (Million USD) by Countries (2014-2018)

7.3.3.  United States

7.3.3.1.  United States Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.4.  Canada

7.3.4.1.  Canada Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.5.  Mexico

7.3.5.1.  Mexico Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.     Europe Biotherapeutics Cell Line by Countries

7.4.1.  Europe Biotherapeutics Cell Line Revenue and Growth Rate (2014-2018)

7.4.2.  Europe Biotherapeutics Cell Line Revenue (Million USD) by Countries (2014-2018)

7.4.3.  Germany

7.4.3.1.  Germany Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.4.  France

7.4.4.1.  France Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.5.  UK

7.4.5.1.  UK Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.6.  Russia

7.4.6.1.  Russia Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.7.  Italy

7.4.7.1.  Italy Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.     Asia-Pacific Biotherapeutics Cell Line by Countries

7.5.1.  Asia-Pacific Biotherapeutics Cell Line Revenue and Growth Rate (2014-2018)

7.5.2.  Asia-Pacific Biotherapeutics Cell Line Revenue (Million USD) by Countries (2014-2018)

7.5.3.  China

7.5.3.1.  China Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.4.  Japan

7.5.4.1.  Japan Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.5.  Korea

7.5.5.1.  Korea Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.  India

7.5.6.1.  India Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.     South America Biotherapeutics Cell Line by Countries

7.6.1.  South America Biotherapeutics Cell Line Revenue and Growth Rate (2014-2018)

7.6.2.  South America Biotherapeutics Cell Line Revenue (Million USD) by Countries (2014-2018)

7.6.3.  Brazil

7.6.3.1.  Brazil Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.4.  Argentina

7.6.4.1.  Argentina Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.5.  Columbia

7.6.5.1.  Columbia Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.     Middle East and Africa Biotherapeutics Cell Line by Countries

7.7.1.  Middle East and Africa Biotherapeutics Cell Line Revenue and Growth Rate (2014-2018)

7.7.2.  Middle East and Africa Biotherapeutics Cell Line Revenue (Million USD) by Countries (2014-2018)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.5.  Egypt

7.7.5.1.  Egypt Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.7.  South Africa

7.7.7.1.  South Africa Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.8.  Turkey

7.7.8.1.  Turkey Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)

8.       Company Profiles

8.1.     Lonza Group

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     Catalent

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     CMC Biologics

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     Thermo Fisher Scientific

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     ProBioGen AG

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Boehringer Ingelheim Pharma GmbH & Co KG

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     Selexis SA

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

8.8.     Sony Biotechnology Inc

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.   Revenue and Market Share

8.9.     Beckman Coulter

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.   Revenue and Market Share

8.10. Partec GmbH

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.       Revenue and Market Share

8.11. Becton Dickinson

8.11.1.      Business Overview

8.11.2.       Service Portfolio

8.11.3.      Strategic Developments

8.11.4.       Revenue and Market Share

9.       Global Biotherapeutics Cell Line Market Competition, by Manufacturer

9.1.     Global Biotherapeutics Cell Line Revenue and Market Share by Manufacturer (2016-2017)

9.2.     Global Biotherapeutics Cell Line Price By Region (2016-2017)

9.3.     Top 5 Biotherapeutics Cell Line Manufacturer Market Share

9.4.     Market Competition Trend

10.    Biotherapeutics Cell Line Market Forecast (2018-2025)

10.1. Global Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2018-2025)

10.2. Biotherapeutics Cell Line Market Forecast by Regions (2018-2025)

10.2.1.      North America Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.1.1. United States Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.1.2. Canada Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.1.3. Mexico Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.2.      Europe Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.2.1. Germany Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.2.2. France Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.2.3. UK Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.2.4. Russia Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.2.5. Italy Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.2.6. Rest of Europe Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.3.      Asia-Pacific Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.3.1. China Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.3.2. Japan Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.3.3. Korea Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.3.4. India Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.3.5. Southeast Asia Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.3.6. Rest of Asia-Pacific Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.4.      South America Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.4.1. Brazil Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.4.2. Argentina Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.4.3. Columbia Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.4.4. Rest of South America Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.5.      Middle East and Africa Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.5.1. Saudi Arabia Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.5.2. United Arab Emirates Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.5.3. Egypt Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.5.4. Nigeria Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.5.5. South Africa Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.5.6. Turkey Biotherapeutics Cell Line Market Forecast (2018-2025)

10.2.5.7. Rest of Middle East and Africa Biotherapeutics Cell Line Market Forecast (2018-2025)

10.3. Biotherapeutics Cell Line Market Forecast by Process (2018-2025)

10.3.1.      Biotherapeutics Cell Line Forecast by Process (2018-2025)

10.3.2.      Biotherapeutics Cell Line Market Share Forecast by Process (2018-2025)

10.4. Biotherapeutics Cell Line Market Forecast by Application (2018-2025)

10.4.1.      Biotherapeutics Cell Line Forecast by Application (2018-2025)

10.4.2.      Biotherapeutics Cell Line Market Share Forecast by Application (2018-2025)


List of Tables

List of Tables and Figures:

Figure United States Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Biotherapeutics Cell Line Revenue and Revenue Share by Process (2014-2018)
Figure Global Single Cell Cloning Revenue and Growth Rate (2014-2018)
Figure Global Transfection & Selection Revenue and Growth Rate (2014-2018)
Table Global Biotherapeutics Cell Line Revenue and Revenue Share by Application (2014-2018)
Figure Global Outsource Revenue and Growth Rate (2014-2018)
Figure Global Do-It-Yourself (DIY) Revenue and Growth Rate (2014-2018)
Figure Global In-house Revenue and Growth Rate (2014-2018)
Figure Global Hybrid Revenue and Growth Rate (2014-2018)
Table Global Biotherapeutics Cell Line Revenue by Regions (2014-2018)
Figure North America Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure North America Biotherapeutics Cell Line Revenue and Growth Rate (2014-2018)
Figure North America Biotherapeutics Cell Line by Countries (2014-2018)
Figure North America Biotherapeutics Cell Line Revenue (Million USD) by Countries (2014-2018)
Figure United States Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure United States Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Canada Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Mexico Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Europe Biotherapeutics Cell Line Revenue and Growth Rate (2014-2018)
Figure Europe Biotherapeutics Cell Line by Countries (2014-2018)
Figure Europe Biotherapeutics Cell Line Revenue (Million USD) by Countries (2014-2018)
Figure Germany Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Germany Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure France Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure UK Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Russia Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Italy Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Rest of Europe Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Asia-Pacific Biotherapeutics Cell Line Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Biotherapeutics Cell Line by Countries (2014-2018)
Figure Asia-Pacific Biotherapeutics Cell Line Revenue (Million USD) by Countries (2014-2018)
Figure China Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure China Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Japan Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Korea Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure India Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Southeast Asia Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure South America Biotherapeutics Cell Line Revenue and Growth Rate (2014-2018)
Figure South America Biotherapeutics Cell Line by Countries (2014-2018)
Figure South America Biotherapeutics Cell Line Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Brazil Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Argentina Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Columbia Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Rest of South America Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Middle East and Africa Biotherapeutics Cell Line Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Biotherapeutics Cell Line by Countries (2014-2018)
Figure Middle East and Africa Biotherapeutics Cell Line Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Saudi Arabia Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure United Arab Emirates Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Egypt Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Nigeria Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure South Africa Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Turkey Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Biotherapeutics Cell Line Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2014-2018)
Table Lonza Group Biotherapeutics Cell Line Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Catalent Biotherapeutics Cell Line Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CMC Biologics Biotherapeutics Cell Line Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Scientific Biotherapeutics Cell Line Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ProBioGen AG Biotherapeutics Cell Line Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Pharma GmbH & Co KG Biotherapeutics Cell Line Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Selexis SA Biotherapeutics Cell Line Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sony Biotechnology Inc Biotherapeutics Cell Line Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Beckman Coulter Biotherapeutics Cell Line Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Partec GmbH Biotherapeutics Cell Line Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Becton Dickinson Biotherapeutics Cell Line Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Biotherapeutics Cell Line Market Share by Manufacturer
Figure Global Biotherapeutics Cell Line Revenue and Market Share by Manufacturer
Table Global Biotherapeutics Cell Line Price by Region (2016-2017)
Figure Top 5 Biotherapeutics Cell Line Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Biotherapeutics Cell Line Revenue (Millions USD) and Growth Rate (2018-2025)
Table Biotherapeutics Cell Line Market Forecast by Regions (2018-2025)
Figure North America Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure United States Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Canada Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Mexico Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Europe Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Germany Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure France Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure UK Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Russia Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Italy Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Rest of Europe Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Asia-Pacific Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure China Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Japan Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Korea Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure India Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Southeast Asia Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure South America Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Brazil Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Argentina Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Columbia Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Rest of South America Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Middle East and Africa Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Saudi Arabia Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure United Arab Emirates Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Egypt Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Nigeria Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure South Africa Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Turkey Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Biotherapeutics Cell Line Market Forecast (2018-2025)
Figure Global Biotherapeutics Cell Line Forecast by Process (2018-2025)
Figure Global Biotherapeutics Cell Line Market Share Forecast by Process (2018-2025)
Figure Global Biotherapeutics Cell Line Forecast by Process (2018-2025)
Figure Global Biotherapeutics Cell Line Forecast by Application (2018-2025)
Figure Global Biotherapeutics Cell Line Market Share Forecast by Application (2018-2025)
Figure Global Biotherapeutics Cell Line Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*